Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Docetaxel and Trabectedin in Recurrent Ovarian Cancer
NCT00569673Phase 2Completed
- Sponsor
- GOG Foundation
- Start
- Mar 2008
- Primary completion
- Jan 2012
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of trabectedin in ovarian cancer, fallopian tube cancer (PFTC), primary peritoneal cancer (PPC), sponsored by GOG Foundation. Started Mar 2008; status: completed.
02
Drugs
trabectedin
03
Conditions
ovarian cancerfallopian tube cancer (PFTC)primary peritoneal cancer (PPC)
Beyond the preview
Go deeper on NCT00569673.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00569673.